NCT00503568: Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy |
|
|
| Completed | 1 | 19 | US | Ad100-gp96Ig-HLA A1, gp96-vaccine, gp96-Ig and HLA A1 transfected Non-Small Cell Lung Cancer cell line | University of Miami | Lung Cancer | 08/12 | 08/12 | | |
NCT01799161: Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer |
|
|
| Withdrawn | 1 | 0 | US | gp96-Ig Vaccine, gp96, AD100-A1-gp96Ig vaccine, Short gp96 Vaccine, gp96IG and HLA A1 Transfected NSCLC Cell Line, Theophylline, dimethylxanthine, Oxygen, O2, Immunologic Evaluation, Peripheral Blood Sample, Tumor Sample | Eckhard Podack | Non-Small Cell Lung Cancer, Non-small-cell Lung Carcinoma, Lung Cancer, NSCLC | 04/18 | | | |
